Feed/Companies/Cognito Therapeutics

Cognito Therapeutics

As of 14 Oct 2026, Cognito Therapeutics has raised $105M across 1 verified round on record; latest: $105 million Series C led by IAG Capital Partners, Morningside Group and 1 other, announced 5 Mar 2026.

BUILT ON

Visit site

Cognitotx sells a non-invasive neuroprotective therapy platform designed to evoke brain wave activity to benefit Alzheimer's patients.

cognitotx.comCambridge, MA

LATEST ROUND

Series C

$105M · 2026-03-05

RAISED ON RECORD · USD

$105M

across 1 verified round

INVESTORS

3 leads

SOURCES

from 1 publisher

Rounds

[ 1 ]

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Round	Amount	Announced	Lead	Buzz
Series C [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$105M	2026-03-05	IAG Capital Partners, Morningside Group, Starbloom Capital	No recent discussion
1 source [ VERIFIED ] read against 1 source [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: businesswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ BRANDING ]logo and colour from the homepage

Cognito Therapeutics

Rounds

Company

Rounds

Sources

Profile

Investors

Cognito Therapeutics

Rounds

Profile

Sources

Series C$105M2026-03-051 source

Investors

Series C$105M2026-03-056 investors